tiprankstipranks
Trending News
More News >
Advertisement

DGRO - ETF AI Analysis

Compare

Top Page

DGRO

iShares Core Dividend Growth ETF (DGRO)

Rating:73Outperform
Price Target:
$76.00
The iShares Core Dividend Growth ETF (DGRO) benefits from strong contributions by holdings like Microsoft (MSFT), which is well-positioned for future growth due to its leadership in cloud and AI services, and Apple (AAPL), which demonstrates robust profitability and strategic global expansion. However, weaker holdings such as AbbVie (ABBV), with valuation concerns and financial leverage risks, slightly temper the fund's overall rating. A key risk factor for DGRO is its exposure to companies with high valuations, which could lead to volatility in certain market conditions.
Positive Factors
Strong Dividend Growth Holdings
Several top holdings, like Johnson & Johnson and Broadcom, have delivered strong year-to-date performance, supporting the ETF's growth.
Sector Diversification
The ETF is spread across multiple sectors, including financials, technology, and healthcare, reducing reliance on any single industry.
Low Expense Ratio
With a very low expense ratio, this ETF allows investors to keep more of their returns compared to higher-cost funds.
Negative Factors
Over-Concentration in U.S. Market
The ETF has almost all of its geographic exposure in the U.S., limiting diversification across global markets.
Underperforming Holdings
Some key holdings, like Procter & Gamble and UnitedHealth, have shown weak year-to-date performance, which could drag on overall returns.
High Weight in Few Stocks
A significant portion of the portfolio is concentrated in a few large companies, increasing exposure to individual stock risks.

DGRO vs. SPDR S&P 500 ETF (SPY)

DGRO Summary

The iShares Core Dividend Growth ETF (DGRO) is an investment fund that focuses on U.S. companies with a strong history of growing their dividend payouts over time. It tracks the Morningstar US Dividend Growth Index and includes well-known companies like Apple and Johnson & Johnson. This ETF is ideal for investors seeking a mix of income and growth, as it prioritizes financially stable firms with sustainable dividend policies, offering potential for steady returns and long-term capital appreciation. However, new investors should be aware that DGRO’s performance can fluctuate with the overall stock market, as it is heavily tied to U.S. market trends.
How much will it cost me?The iShares Core Dividend Growth ETF (DGRO) has an expense ratio of 0.08%, which means you’ll pay $0.80 per year for every $1,000 invested. This is lower than average because it’s a passively managed fund that tracks an index, keeping costs down for investors.
What would affect this ETF?The iShares Core Dividend Growth ETF (DGRO) could benefit from stable economic growth and favorable interest rate conditions, which often support dividend-paying companies, especially in sectors like technology and healthcare. However, rising interest rates or economic downturns could negatively impact dividend growth and the performance of financial and consumer sectors, which are significant parts of the ETF's portfolio. Regulatory changes or sector-specific challenges, such as increased scrutiny on healthcare or technology companies, could also pose risks to its top holdings like Apple, Johnson & Johnson, and Microsoft.

DGRO Top 10 Holdings

The iShares Core Dividend Growth ETF (DGRO) leans heavily on U.S. dividend growers, with a notable tilt toward technology, financials, and healthcare. Apple and Microsoft are steady performers, buoyed by their focus on AI and cloud services, while Broadcom’s rising momentum in semiconductors adds a spark to the tech-heavy lineup. On the healthcare front, Johnson & Johnson and AbbVie are climbing steadily, driven by strong earnings and strategic investments. However, Procter & Gamble and Home Depot are lagging, holding back consumer sectors with slowing growth and bearish signals. Overall, DGRO’s sector mix offers resilience but faces headwinds in consumer-focused names.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Apple3.32%$1.14B$3.99T18.75%
80
Outperform
JPMorgan Chase3.13%$1.07B$848.47B32.59%
72
Outperform
Johnson & Johnson3.06%$1.05B$448.13B19.29%
78
Outperform
Exxon Mobil3.05%$1.05B$479.41B-5.49%
75
Outperform
Microsoft2.95%$1.01B$3.77T16.85%
82
Outperform
AbbVie2.81%$965.57M$383.12B9.24%
62
Neutral
Broadcom2.61%$894.49M$1.70T93.46%
76
Outperform
Procter & Gamble2.12%$727.36M$340.67B-10.57%
74
Outperform
Coca-Cola1.90%$651.85M$294.70B8.48%
78
Outperform
UnitedHealth1.87%$642.29M$296.88B-46.89%
76
Outperform

DGRO Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price
Price Trends
50DMA
67.70
Negative
100DMA
66.15
Positive
200DMA
63.55
Positive
Market Momentum
MACD
0.02
Positive
RSI
43.99
Neutral
STOCH
17.40
Positive
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For DGRO, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 68.08, equal to the 50-day MA of 67.70, and equal to the 200-day MA of 63.55, indicating a neutral trend. The MACD of 0.02 indicates Positive momentum. The RSI at 43.99 is Neutral, neither overbought nor oversold. The STOCH value of 17.40 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for DGRO.

DGRO Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$34.43B0.08%
73
Outperform
$559.74B0.03%
74
Outperform
$97.99B0.05%
74
Outperform
$79.08B0.03%
74
Outperform
$52.34B0.15%
77
Outperform
$38.74B0.17%
73
Outperform
Performance Comparison
Ticker
Company Name
Price
Change
% Change
DGRO
iShares Core Dividend Growth ETF
67.51
4.73
7.53%
VTI
Vanguard Total Stock Market ETF
VIG
Vanguard Dividend Appreciation ETF
ITOT
iShares Core S&P Total U.S. Stock Market ETF
QUAL
iShares MSCI USA Quality Factor ETF
DFAC
Dimensional U.S. Core Equity 2 ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement